Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P762: Onset of inflammatory bowel disease during treatment with secukinumab: Can anti-IL-17A be a trigger for inflammatory bowel disease?

ECCO '19 Copenhagen

Year: 2019
Authors:

R. Rodríguez Moncada*1, J. M. Vázquez Morón1, M. Rojas Feria2, J. M. Herrera Justiniano3, B. Maldonado Pérez4, M. Castro Fernández2, A. Núñez Ortiz3, V. Cabello Rubio3, H. Pallarés Manrique1, E. Gómez Delgado1, A. Bejarano García1

1Hospital Juan Ramón Jiménez, Gastroenterology Unit, Huelva, Spain, 2Universitary Hospital Virgen de Valme, Gastroenterology Unit, Seville, Spain, 3Universitary Hospital Virgen del Rocío, Gastroenterology Unit, Seville, Spain, 4Universitary Hospital Virgen de la Macarena, Gastroenterology Unit, Seville, Spain

P763: Addiction in IBD patients: more than just smoke?

ECCO '19 Copenhagen

Year: 2019
Authors:

S. Hirschmann1, J. Koehnen*1, B. Schuster2, R. Atreya1, N. Krauss3, J. Mudter4, M. Dauer5, A. Hagel6, M. F. Neurath1, H. Albrecht1,7

1University Erlangen-Nuremberg, Medical Clinic 1, Erlangen, Germany, 2Technical University of Munich, Clinic and Polyclinic for dermatology and allergology Biederstein, Munich, Germany, 3University Hospital of Giessen, Central Interdisciplinary Visceral Medical Endoscopy (ZIVE), Giessen, Germany, 4Hospital Helios Schwerin, Clinic for Gastroenterology and Infectiology, Schwerin, Germany, 5Hospital St. Marien Amberg, Clinic for Internal Medicine II, Amberg, Germany, 6Practice Clinic Schwabach, Schwabach, Germany, 7Hospital Neumarkt, Medical Clinic 2, Neumarkt, Germany

P764: Prevalence of Autoimmune diseases among first- and second-degree relatives of patients with inflammatory bowel diseases. A case–control survey in Israel

ECCO '19 Copenhagen

Year: 2019
Authors:

T. Khoury*1, A. Mari2, L. Mhamed3, M. Mahamid4

1EMMS, Nazareth Hospital, Gastroenterology, Nazareth, Israel, 2EMMS, Nazarieth Hospital, Gastroenterology, Nazareth, Israel, 3Meir Medical Centre, Internal Medicine C, Kfar Saba, Israel, 4EMMS, Nazareth, Gastroenterology, Nazareth, Israel

P765: A description of inflammatory bowel disease patients’ beliefs in their medications, in comparison with patients with other chronic conditions

ECCO '19 Copenhagen

Year: 2019
Authors:

I. Marín-Jiménez*1, D. Orozco-Beltrán2, J. Toro3, M. J. Galindo4, B. Juliá5, L. Cea-Calvo6

1Hospital Universitario Gregorio Marañón, Gastroenterology, Madrid, Spain, 2Miguel Hernández University, Medicine, Sant Joan, Alicante, Spain, 3Hospital Universitario A Coruña, Universidade da Coruña, INIBIC, Rheumatology, A Coruña, Spain, 4Clinic University Hospital, Internal Medicine, Valencia, Spain, 5Medical Affairs, Merck Sharp & Dohme, Madrid, Spain, 6Medical Affairs, Merck Sharp & Dohme, Spain, Madrid, Spain

P766: Differences among disease pattern, medication use, surgery and hospitalisation rates in a low prevalence of ulcerative colitis population: A retrospective cohort from Bangkok, Thailand

ECCO '19 Copenhagen

Year: 2019
Authors:

S. Aniwan*1, J. Limsrivilai2

1Chulalongkorn University, Internal Medicine, Bangkok, Thailand, 2Siriraj Hospital, Internal Medicine, Bangkok, Thailand

P767: Non-adherence behaviours of patients with inflammatory bowel disease and other chronic conditions. Relationship with experience with healthcare and beliefs in medications

ECCO '19 Copenhagen

Year: 2019
Authors:

I. Marín-Jiménez*1, D. Orozco-Beltrán2, J. Toro3, M. J. Galindo4, B. Juliá5, L. Cea-Calvo6

1Hospital Universitario Gregorio Marañón, Gastroenterology, Madrid, Spain, 2Miguel Hernández University, Medicine, Sant Joan, Alicante, Spain, 3Hospital Universitario A Coruña, Universidade da Coruña, INIBIC, Rheumatology, A Coruña, Spain, 4Clinic University Hospital, Internal Medicine, Valencia, Spain, 5Medical Affairs, Merck Sharp & Dohme, Madrid, Spain, 6Medical Affairs, Merck Sharp & Dohme, Spain, Madrid, Spain

P768: Development and validation of Processed Foods Questionnaire (PFQ) in Israeli adult inflammatory bowel diseases patients

ECCO '19 Copenhagen

Year: 2019
Authors:

C. Sarbagili-Shabat*1,2, S. Zelber-Sagi1,3, N. Fliss Isakov1, Y. Ron1, A. Hirsh1, N. Maharshak1,2

1Tel-Aviv Medical Center, IBD Center, Department of Gastroenterology and Liver Diseases, Tel Aviv, Israel, 2Tel-Aviv University, The Sackler Faculty of Medicine, Tel-Aviv, Israel, 3University of Haifa, School of Public Health, Haifa, Israel

P769: Seasonal variations in acute hospital admissions with inflammatory bowel disease

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Yadav*1, E. Kelly1, P. R. Armstrong1, M. N. Fauzi1, C. McGarry1, C. Shaw1, B. Hall1, O. Kelly1, C. Smyth1, R. J. Farrell1

1Connolly Hospital and RCSI, Blanchardstown, Dublin 15, Department of Gastroenterology, Dublin, Ireland

P770: Epidemiology of inflammatory bowel diseases in French Polynesia

ECCO '19 Copenhagen

Year: 2019
Authors:

V. Grymonpré1, A. Loria2, E. Beaugendre2, B. Condat2, B. Tassy1, N. Bouta1, M. Bismuth1, F. Panaro3, J-C. Valats1, P. Blanc1, G. Pineton de Chambrun*1

1Montpellier University Hospital, Gastroenterology, Montpellier, France, 2French Polynesia General Hospital, Gastroenterology, Papeete, French Polynesia, 3Montpellier University Hospital, Digestive Surgery, Montpellier, France

P771: Predictors of health-related quality of life in patients with moderate to severely active ulcerative colitis receiving biological therapy

ECCO '19 Copenhagen

Year: 2019
Authors:

B. Rasmussen*1, P. Haastrup1, S. Wehberg1, J. Kjeldsen2,3, F. Boch Waldorff1

1University of Southern Denmark, Research Unit of General Practice, Department of Public Health, Odense, Denmark, 2Odense University Hospital, Department of Medical Gastroenterology, Odense, Denmark, 3Institute of Clinical Research, Odense, Denmark

P772: Development and validation of tools to assess food additive intake: the ENIGMA study

ECCO '19 Copenhagen

Year: 2019
Authors:

G. Trakman*1,2, W. Y. Y. Lin3, A. Wilson-O'brien1,2, J. Ching3,4, W. Tang3,4, L. Orr3,4, A. Stanley2, A. L. Hamilton1,2, M. Morrison5, J. Yu3,4, J. J. Sung3,4, S. C. Ng3,4,6, M. A. Kamm1,2

1University of Melbourne, Department of Medicine, Melbourne, Australia, 2St Vincent's Hospital, Department of Gastroenterology, Melbourne, Australia, 3The Chinese University of Hong Kong, Department of Medicine and Therapeutics, Hong Kong, Hong Kong, 4The Chinese University of Hong Kong, Institute of Digestive Disease, State Key Laboratory of Digestive Diseases, Hong Kong, Hong Kong, 5The University of Queensland, Diamantina Institute, Faculty of Medicine, Translational Research Institute, Brisbane, Australia, 6The Chinese University of Hong Kong, Centre for Gut Microbiota Research, Hong Kong, Hong Kong

P773: Sarcopenia is a new risk factor of non-alcoholic fatty liver disease in patients with inflammatory bowel disease

ECCO '19 Copenhagen

Year: 2019
Authors:

B. I. Jang*1, K. O. Kim1,2, C. H. Yang3

1Yeungnam University College of Medicine, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Daegu, South Korea, 2Virginia Mason Medical Center, Digestive Disease Institute, Seattle, USA, 3Dongguk University College of Medicine, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Kyeongju, South Korea

P774: Higher plasma cotinine is associated with an increased risk for later developing IBD, especially among users of combusted tobacco

ECCO '19 Copenhagen

Year: 2019
Authors:

L. Widbom*1, J. Schneede2, P. Karling3, J. Hultdin1

1Umeå University, Department of medical bioscienses, clinical chemistry, Umeå, Sweden, 2Umeå University, Department of pharmacology and clinical neuroscience, Umeå, Sweden, 3Umeå University, Department of public health and clinical medicine, Umeå, Sweden

P775: Finger clubbing and Crohn's disease: higher frequency in patients with upper GI lesions in a prospective study

ECCO '19 Copenhagen

Year: 2019
Authors:

S. Romeo1, B. Neri*1, E. Lolli1, E. Calabrese1, E. De Cristofaro1, C. Gesuale1, L. Biancone1

1University of Rome 'Tor Vergata', Gastroenterology, Rome, Italy

P776: Factors associated with quality of care perceived by patients in IBD units from Spain. Analysis from IQCARO project

ECCO '19 Copenhagen

Year: 2019
Authors:

F. Casellas1, D. Carpio2, M. Minguez3, I. Vera4, B. Juliá*5, L. Marin6, R. Saldaña7, L. Cea5, X. Calvet8

1Hospital Vall d′Hebron, Gastroenterology Department, Barcelona, Spain, 2Complejo Hospitalario de Pontevedra, Gastroenterology Unit, Pontevedra, Spain, 3Hospital Clínico Universitario, Unidad de Gastroenterología, Valencia, Spain, 4Hospital Universitario Puerta de Hierro, Servicio de Gastroenterologia, Madrid, Spain, 5Medical Department, MSD, Madrid, Spain, 6Hospital Universitari Germans Trias i Pujol, Gastroenterology Unit, Badalona, Spain, 7Spanish Association of patients with Crohn′s disease and Ulcerative colitis, Madrid, Spain, 8Institut Universitari Parc Taulí, Digestive Unit, Sabadell, Spain

P777: The cancer incidence in paediatric onset inflammatory bowel disease: a population-based study from Denmark

ECCO '19 Copenhagen

Year: 2019
Authors:

M. Malham*1, C. Jakobsen1,2, A. Paerregaard1, L. B. Riis3, K-L. Kolho4, V. Wewer1

1Hvidovre University Hospital, The Paediatric Department, Hvidovre, Denmark, 2Hvidovre University Hospital, The GastroUnit, Hvidovre, Denmark, 3Herlev Hospital, The Department of Pathology, Herlev, Denmark, 4Tampere University Hospital, The Paediatric Department, Tampere, Finland

P778: Risk of cancer in paediatric onset inflammatory bowel disease: a nationwide cohort study 1977–2014

ECCO '19 Copenhagen

Year: 2019
Authors:

V. S. Kjærgaard1,2, C. B. Jensen1, J. Burisch1,3, K. Allin1, T. Jess*1

1Bispebjerg and Frederiksberg Hospital, Center for Clinical Research and Prevention, Copenhagen, Denmark, 2University of Glasgow, Glasgow, UK, 3Bispebjerg and Frederiksberg Hospital, Abdominal Centre K, Copenhagen, Denmark

P779: Extra intestinal manifestations and other comorbidities in Crohn’s disease and Ulcerative colitis are equally likely to appear before IBD diagnosis: a Danish nationwide registry study from 2003 to 2015

ECCO '19 Copenhagen

Year: 2019
Authors:

K. Vadstrup*1, S. Alulis1, A. Borsi2, T. R. Jørgensen3, A. Nielsen4, P. Munkholm5, N. Qvist6

1Janssen Immunology, Birkerød, Denmark, 2Janssen Immunology, High Wycombe, UK, 3Leo Pharma, Ballerup, Denmark, 4Incentive, Holte, Denmark, 5North Zealand University Hospital, Frederikssund, Denmark, 6Odense University Hospital, Odense, Denmark

P780: Medical treatment and surgery in patients with elderly-onset inflammatory bowel disease: 3-year follow-up of Epi-IBD 2010–2011 cohorts

ECCO '19 Copenhagen

Year: 2019
Authors:

V. Hernandez*1, J. Martinez-Cadilla1, E. Langholz2, D. Christodoulou3, S. Turcan4, D. Valpiani5, P. L. Lakatos6, Z. Vegh6, A. Goldis7, E. Belousova8, K. Ladefoged9, G. Kiudelis10, D. McNamara11, O. Shonova12, Z. Krznarić13, F. Magro14, E. S. Bjornsson15, S. Almer16, M. Fumery17, D. Duricova18, A. Kievit19, I. Kaimakliotis20, P. Ellul21, O. Niewiadomski22, M. Giannotta23, S. Odes24, N. Pedersen25, J. F. Dahlerup26, J. F. Dahlerup26, R. Salupere27, R. D'Incà28, R. D'Incà28, J. Halfvarson29, P. Oksanen30, N. Arebi31, K. R. Nielsen32, V. Andersen33, S. Shaji34, P. Munkholm35, J. Burisch35, Epi-IBD-group1

1Instituto de Investigación Sanitaria Galicia Sur. Hospital Alvaro Cunqueiro. EOXI Vigo, Gastroenterology, Vigo, Spain, 2Gentofte Hospital, Medical Gastroenterology, Copenhagen, Denmark, 3University Hospital Ioannina, 1st Division of Internal Medicine and Hepato-Gastroenterology Unit, Ioannina, Greece, 4State University of Medicine and Pharmacy of the Republic of Moldova, Gastroenterology, Chisinau, Moldova, Republic of, 5Morgagni Hospital, Gastroenterology and Digestive Endoscopy, Forli, Italy, 6Semmelweis University, 1st Department of Medicine, Budapest, Hungary, 7University of Medicine ‘Victor Babes’, Clinic of Gastroenterology, Timisoara, Romania, 8Moscow Regional Research Clinical Institute, Gastroenterology, Moscow, Russian Federation, 9Dronning Ingrids Hospital, Medical Department, Nuuk, Greenland, 10Lithuanian University of Health Sciences, Institute for Digestive Research, Kaunas, Lithuania, 11Adelaide and Meath Hospital, Gastroenterology, Dublin, Ireland, 12Hospital Ceské Budejovice, Gastroenterology, Ceské Budejovice, Czech Republic, 13University Hospital Center Zagreb, Gastroenterology, Zagreb, Croatia, 14Hospital de São João, Porto; Institute of Pharmacology and Therapeutics, Oporto Medical School and Institute for molecular and cell biology, Gastroenterology, Porto, Portugal, 1521Landspitali - The National University Hospital of Iceland, Gastroenterology, Reykjavik, Iceland, 16Karolinska Institutet, GastroCentrum, Stockholm, Sweden, 17Amiens University and Hospital, Epimad Registry, Gastroenterology Unit, Amiens, France, 18Charles University, IBD Center ISCARE, Prague, Czech Republic, 19Herning Central Hospital, Medicine, Herning, Denmark, 20Private Practice, Nicosia, Cyprus, 21Mater Dei Hospital, Gastroenterology, Msida, Malta, 22St Vincent's Hospital, Gastroenterology, Melbourne, Australia, 23AOU Careggi Regional Referral Center for Inflammatory Bowel Disease, Gastroenterology, Florence, Italy, 24Soroka Medical Center and Ben Gurion University of the Negev, Gastroenterology and Hepatology, Beer Sheva, Israel, 25Slagelse Hospital, Gastroenterology, Slagelse, Denmark, 26Arhus University Hospital, Medicine V (Hepatology and Gastroenterology), Arhus, Denmark, 27Tartu University Hospital, Endocrinology and Gastroenterology, Tartu, Estonia, 28Azienda Ospedaliera di Padova, Surgery, Oncology and Gastroenterology, Padova, Italy, 29Faculty of Medicine and Health, Gastroenterology, Orebro, Sweden, 30Tampere University Hospital, Gastroenterology and Alimentary Tract Surgery, Tampere, Finland, 31St. Mark's Hospital, Imperial College London, Gastroenterology, London, UK, 32The National Hospital of the Faroe Islands, Medical Department, Torshavn, Faroe Islands, 33Regional Hospital of Viborg, Medical Department, Viborg, Denmark, 34Hull and East Yorkshire NHS Trust, IBD Unit, Hull, UK, 35North Zealand University Hospital, Gastroenterology, Frederikssund, Denmark

P781: Defining the economic burden of venous thromboembolism after surgery for inflammatory bowel disease in the USA: a national inpatient sample study

ECCO '19 Copenhagen

Year: 2019
Authors:

C. H. A. Lee1, A. Aiello2, L. Stocchi1, J. Lipman1, S. Shawki1, T. Hull1, S. Steele1, S. Holubar*1

1Cleveland Clinic, Colon and Rectal Surgery, Cleveland, USA, 2Cleveland Clinic, Quantitative Health Sciences, Cleveland, USA